Cargando…
Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies
A mass spectrometric analysis platform has been developed to determine whether glycosylation patterns of alpha-1 acid glycoprotein (AGP) could be used as a marker for early detection of hepatocellular carcinoma (HCC) in different etiologies, i.e. non-alcoholic steatohepatitis (NASH), alcoholic liver...
Autores principales: | Liang, Jing, Zhu, Jianhui, Wang, Mengmeng, Singal, Amit G., Odewole, Mobolaji, Kagan, Sofia, Renteria, Veronica, Liu, Suyu, Parikh, Neehar D., Lubman, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689003/ https://www.ncbi.nlm.nih.gov/pubmed/31399619 http://dx.doi.org/10.1038/s41598-019-48043-1 |
Ejemplares similares
-
A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
por: Lin, Yu, et al.
Publicado: (2022) -
Analysis of Serum Haptoglobin
Fucosylation in Hepatocellular
Carcinoma and Liver Cirrhosis of Different Etiologies
por: Zhu, Jianhui, et al.
Publicado: (2014) -
Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin
as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular
Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel
Reaction Monitoring-Mass Spectrometry Method
por: Lin, Yu, et al.
Publicado: (2022) -
Discovery of Core-Fucosylated Glycopeptides as Diagnostic
Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS
por: Tan, Yifei, et al.
Publicado: (2023) -
PRM-MS Quantitative Analysis of Isomeric N-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
por: Gutierrez Reyes, Cristian D., et al.
Publicado: (2021)